MedMen - NAPKIN MATH INCLUDING PHARMACANN REVENUEHere is an overview of what to expect for Fiscal 2019...
Medmen's last quarter...
$21.5 Million USD Revenue
x 4 quarters = $86,000,000 USD
PharmaCann Annual Revenue...
$35,000,000 USD
MedMen & PharmaCann Combined Revenue...
$121,000,000 USD x 1.36 (CDN exchange)
= (Approx) $165,000,000 CDN per year
or... $41,250,000 CDN per quarter
Currently we only have data from Q1 - 2019 for Medmen so we need to account for a few things still...
#1 - Revenue in Canada from JV with Cronos Group
#2 - Future growth of revenues as new stores open in 2019
Medmen is already selling in Canada in British Clombia and Nova Scotia, we have no clear indication of sales volume but the reviews are looking really good on reddit etc...
#1 - I value the 50% of the Canadian Revenue at $2.5 million per quarter
#2 - Future growth for a newly forming company is much faster than with a a mature company. Medmen is no exception. They grew revenues by over 1000% YOY in Q1 - 2019
I will assume this trend to continue and believe that Medmen will grow revenues by at least 25% per quarter for the next 3 reporting periods.
With that being said let see what it looks like...
$29,240,000 (current) per Quarter
+ 2,500,000 (Canadian JV) Q2 - 2019
+ 11,900,000 CDN (Pharmacann) Q2- 2019
= $43,640,000 CDN dollars
+ 25% Revenue growth in Q2
= $54,550,000 CDN - Q2 - 2019
x 25 % Revenue growth in Q3
= $68,187,500 CDN - Q3 - 2019
x 25% Revenue growth in Q4
= $85,234,375 CDN - Q4 - 2019
Providing this plays out, it would mean Medmen would bring in aprrox...
$29,240,000 Q1 -2019
+ $54,550,000 CDN - Q2 - 2019
+ $68,187,500 CDN - Q3 - 2019
+ $85,234,375 CDN - Q4 - 2019
= $237,211,875 CDN - FISCAL 2019